Comprehensive Stock Comparison
Compare Community Healthcare Trust Incorporated (CHCT) vs Global Medical REIT Inc. (GMRE) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | CHCT | 4.8% revenue growth vs GMRE's -1.8% |
| Value | CHCT | Lower P/E (36.4x vs 620.0x) |
| Quality / Margins | CHCT | 4.2% net margin vs GMRE's 1.7% |
| Stability / Safety | CHCT | Beta 0.42 vs GMRE's 0.58 |
| Dividends | CHCT | 11.7% yield, 11-year raise streak, vs GMRE's 61.0% |
| Momentum (1Y) | CHCT | +1.3% vs GMRE's -8.0% |
| Efficiency (ROA) | CHCT | 0.5% ROA vs GMRE's 0.2%, ROIC 5.6% vs 2.0% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Community Healthcare Trust is a real estate investment trust that owns and leases outpatient healthcare facilities across the United States. It generates revenue primarily through rental income from long-term triple-net leases to healthcare tenants — with medical office buildings, surgery centers, and specialty clinics forming its core portfolio. The company's moat lies in its specialized focus on recession-resistant healthcare real estate and its geographically diversified portfolio of essential medical properties.
Global Medical REIT is a specialized real estate investment trust that acquires and leases purpose-built medical office buildings and healthcare facilities to leading healthcare providers. It generates revenue primarily through long-term triple-net leases—where tenants cover most property expenses—with its portfolio concentrated in medical office buildings (roughly 85% of assets) and inpatient rehabilitation hospitals. The company's competitive advantage lies in its specialized focus on mission-critical healthcare real estate—which tends to be recession-resistant—and its relationships with creditworthy healthcare systems that provide stable, long-term cash flows.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
CHCT leads in 3 of 6 categories (Financial Metrics, Profitability & Efficiency). GMRE leads in 2 (Valuation Metrics, Total Returns). 1 tied.
Financial Metrics (TTM)
GMRE and CHCT operate at a comparable scale, with $148M and $121M in trailing revenue. Profitability is closely matched — net margins range from 4.2% (CHCT) to 1.7% (GMRE). On growth, GMRE holds the edge at +18.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | CHCTCommunity Healthc… | GMREGlobal Medical RE… |
|---|---|---|
| RevenueTrailing 12 months | $121M | $148M |
| EBITDAEarnings before interest/tax | $116M | $95M |
| Net IncomeAfter-tax profit | $5M | $2M |
| Free Cash FlowCash after capex | $56M | $19M |
| Gross MarginGross profit ÷ Revenue | +80.5% | +68.8% |
| Operating MarginEBIT ÷ Revenue | +59.9% | +24.9% |
| Net MarginNet income ÷ Revenue | +4.2% | +1.7% |
| FCF MarginFCF ÷ Revenue | +46.5% | +12.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.1% | +18.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +11.2% | -166.2% |
Valuation Metrics
At 120.0x trailing earnings, GMRE trades at a 46% valuation discount to CHCT's 220.8x P/E. On an enterprise value basis, CHCT's 8.8x EV/EBITDA is more attractive than GMRE's 12.9x.
| Metric | CHCTCommunity Healthc… | GMREGlobal Medical RE… |
|---|---|---|
| Market CapShares × price | $487M | $499M |
| Enterprise ValueMkt cap + debt − cash | $1.0B | $1.1B |
| Trailing P/EPrice ÷ TTM EPS | 220.80x | 120.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 36.36x | 620.00x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 8.84x | 12.91x |
| Price / SalesMarket cap ÷ Revenue | 4.01x | 3.60x |
| Price / BookPrice ÷ Book value/share | 1.07x | 0.18x |
| Price / FCFMarket cap ÷ FCF | 8.62x | — |
Profitability & Efficiency
CHCT delivers a 1.2% return on equity — every $100 of shareholder capital generates $1 in annual profit, vs $0 for GMRE. GMRE carries lower financial leverage with a 1.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to CHCT's 1.26x. On the Piotroski fundamental quality scale (0–9), CHCT scores 7/9 vs GMRE's 4/9, reflecting strong financial health.
| Metric | CHCTCommunity Healthc… | GMREGlobal Medical RE… |
|---|---|---|
| ROE (TTM)Return on equity | +1.2% | +0.5% |
| ROA (TTM)Return on assets | +0.5% | +0.2% |
| ROICReturn on invested capital | +5.6% | +2.0% |
| ROCEReturn on capital employed | +8.3% | +5.3% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 |
| Debt / EquityFinancial leverage | 1.26x | 1.18x |
| Net DebtTotal debt minus cash | $540M | $647M |
| Cash & Equiv.Liquid assets | $3M | $7M |
| Total DebtShort + long-term debt | $543M | $654M |
| Interest CoverageEBIT ÷ Interest expense | 2.13x | 1.14x |
Total Returns (with DRIP)
A $10,000 investment in GMRE five years ago would be worth $8,626 today (with dividends reinvested), compared to $6,001 for CHCT. Over the past 12 months, CHCT leads with a +1.3% total return vs GMRE's -8.0%. The 3-year compound annual growth rate (CAGR) favors GMRE at -0.9% vs CHCT's -16.4% — a key indicator of consistent wealth creation.
| Metric | CHCTCommunity Healthc… | GMREGlobal Medical RE… |
|---|---|---|
| YTD ReturnYear-to-date | +7.6% | +9.8% |
| 1-Year ReturnPast 12 months | +1.3% | -8.0% |
| 3-Year ReturnCumulative with dividends | -41.5% | -2.8% |
| 5-Year ReturnCumulative with dividends | -40.0% | -13.7% |
| 10-Year ReturnCumulative with dividends | +90.5% | +319.0% |
| CAGR (3Y)Annualised 3-year return | -16.4% | -0.9% |
Risk & Volatility
CHCT is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than GMRE's 0.58 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHCT currently trades 89.9% from its 52-week high vs GMRE's 81.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CHCTCommunity Healthc… | GMREGlobal Medical RE… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.42x | 0.58x |
| 52-Week HighHighest price in past year | $19.01 | $45.75 |
| 52-Week LowLowest price in past year | $13.23 | $29.05 |
| % of 52W HighCurrent price vs 52-week peak | +89.9% | +81.3% |
| RSI (14)Momentum oscillator 0–100 | 47.9 | 53.8 |
| Avg Volume (50D)Average daily shares traded | 180K | 72K |
Analyst Outlook
Wall Street rates CHCT as "Hold" and GMRE as "Buy". Consensus price targets imply 8.3% upside for CHCT (target: $19) vs 7.5% for GMRE (target: $40). For income investors, GMRE offers the higher dividend yield at 61.02% vs CHCT's 11.69%.
| Metric | CHCTCommunity Healthc… | GMREGlobal Medical RE… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $18.50 | $40.00 |
| # AnalystsCovering analysts | 16 | 22 |
| Dividend YieldAnnual dividend ÷ price | +11.7% | +61.0% |
| Dividend StreakConsecutive years of raises | 11 | 5 |
| Dividend / ShareAnnual DPS | $2.00 | $22.70 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Mar 20 | Feb 26 | Change |
|---|---|---|---|
| Community Healthcar… (CHCT) | 100 | 34.79 | -65.2% |
| Global Medical REIT… (GMRE) | 100 | 48.27 | -51.7% |
Global Medical REIT… (GMRE) returned -14% over 5 years vs Community Healthcar… (CHCT)'s -40%.
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Community Healthcar… (CHCT) | $25M | $121M | +381.6% |
| Global Medical REIT… (GMRE) | $8M | $138M | +1613.1% |
Community Healthcare Trust Incorporated's revenue grew from $25M (2016) to $121M (2025) — a 19.1% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Community Healthcar… (CHCT) | 10.8% | 4.2% | -61.1% |
| Global Medical REIT… (GMRE) | -78.6% | 4.8% | +106.1% |
Community Healthcare Trust Incorporated's net margin went from 11% (2016) to 4% (2025).
Chart 4P/E Ratio History — 9 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| Community Healthcar… (CHCT) | 147.9 | 212.1 | +43.4% |
| Global Medical REIT… (GMRE) | 2.9 | 124.5 | +4193.1% |
Community Healthcare Trust Incorporated has traded in a 44x–212x P/E range over 8 years; current trailing P/E is ~221x. Global Medical REIT Inc. has traded in a 3x–125x P/E range over 3 years; current trailing P/E is ~120x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Community Healthcar… (CHCT) | 0.24 | 0.08 | -67.8% |
| Global Medical REIT… (GMRE) | -17 | 0.31 | +101.8% |
Community Healthcare Trust Incorporated's EPS grew from $0.24 (2016) to $0.08 (2025) — a -12% CAGR.
Chart 6Free Cash Flow — 5 Years
Community Healthcare Trust Incorporated generated $56M FCF in 2025 (+15% vs 2021). Global Medical REIT Inc. generated $-25M FCF in 2024 (+81% vs 2021).
CHCT vs GMRE: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is CHCT or GMRE a better buy right now?
Global Medical REIT Inc. (GMRE) offers the better valuation at 120.0x trailing P/E (620.0x forward), making it the more compelling value choice. Analysts rate Global Medical REIT Inc. (GMRE) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CHCT or GMRE?
On trailing P/E, Global Medical REIT Inc. (GMRE) is the cheapest at 120.0x versus Community Healthcare Trust Incorporated at 220.8x. On forward P/E, Community Healthcare Trust Incorporated is actually cheaper at 36.4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CHCT or GMRE?
Over the past 5 years, Global Medical REIT Inc. (GMRE) delivered a total return of -13.7%, compared to -40.0% for Community Healthcare Trust Incorporated (CHCT). A $10,000 investment in GMRE five years ago would be worth approximately $9K today (assuming dividends reinvested). Over 10 years, the gap is even starker: GMRE returned +319.0% versus CHCT's +90.5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CHCT or GMRE?
By beta (market sensitivity over 5 years), Community Healthcare Trust Incorporated (CHCT) is the lower-risk stock at 0.42β versus Global Medical REIT Inc.'s 0.58β — meaning GMRE is approximately 38% more volatile than CHCT relative to the S&P 500. On balance sheet safety, Global Medical REIT Inc. (GMRE) carries a lower debt/equity ratio of 118% versus 126% for Community Healthcare Trust Incorporated — giving it more financial flexibility in a downturn.
05Which has better profit margins — CHCT or GMRE?
Global Medical REIT Inc. (GMRE) is the more profitable company, earning 4.8% net margin versus 4.2% for Community Healthcare Trust Incorporated — meaning it keeps 4.8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CHCT leads at 59.9% versus 23.6% for GMRE. At the gross margin level — before operating expenses — CHCT leads at 80.5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is CHCT or GMRE more undervalued right now?
On forward earnings alone, Community Healthcare Trust Incorporated (CHCT) trades at 36.4x forward P/E versus 620.0x for Global Medical REIT Inc. — 583.6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CHCT: 8.3% to $18.50.
07Which pays a better dividend — CHCT or GMRE?
All stocks in this comparison pay dividends. Global Medical REIT Inc. (GMRE) offers the highest yield at 61.0%, versus 11.7% for Community Healthcare Trust Incorporated (CHCT).
08Is CHCT or GMRE better for a retirement portfolio?
For long-horizon retirement investors, Global Medical REIT Inc. (GMRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.58), 61.0% yield, +319.0% 10Y return). Both have compounded well over 10 years (GMRE: +319.0%, CHCT: +90.5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between CHCT and GMRE?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.